Skip to main content
Log in

Distribution Kinetics of Salicylic Acid in the Isolated Perfused Rat Liver Assessed Using Moment Analysis and the Two-Compartment Axial Dispersion Model

  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Abstract

The distribution kinetics of salicylic acid in the single-pass isolated perfused rat liver has been investigated under varying conditions of perfusate flow (15 to 30 ml min−1) and of salicylate perfusate concentration (0, 100, 200 mg 1−1) using statistical moment analysis and the two-compartment axial dispersion model. Salicylic acid was not metabolised during the experiment. The perfusate did not contain binding protein. As flow rate was increased, the maximum fraction output per second (f(t)max) increased and the mean transit time (MTTH) decreased, while tmax became shorter for both tritiated water and 14C-salicylic acid. Increasing the salicylate perfusate concentration profoundly affected the frequency outflow profile of 14C-salicylic acid, but not that of tritiated water. The one-compartment axial dispersion model adequately described the frequency outflow profile for tritiated water, whereas the two-compartment form, which incorporates a cellular permeability barrier, provided a better description of the 14C-salicylic acid outflow data. The estimated two-compartment axial dispersion model parameters for 14C-salicylic acid, DN, the dispersion number (0.08 ± 0.03), k12, the influx rate constant (0.56 ± 0.04 sec−1) and k21, the efflux rate constant (0.095 ± 0.01 sec−1) were independent of perfusate flow rate. The in situ permeability-surface area product for 14C-salicylic acid (4.6 ± 0.7 ml min−1g−1 liver) was in good agreement with literature estimates obtained from in vitro hepatocyte experiments, suggesting that the permeability barrier is at the hepatocyte membrane. Whereas DN and k12 were uninfluenced by, k21 displayed a positive correlation with, salicylate perfusate concentration. This correlation was most likely due to decreased intracellular salicylate binding.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

REFERENCES

  1. G. R. Wilkinson. Clearance approaches in pharmacology. Pharmacol. Rev. 39:1–45 (1987).

    Google Scholar 

  2. M. Rowland, D. Leitch, G. Fleming, B. Smith. Protein binding and hepatic clearance: discrimination between models of hepatic clearance with diazepam, a drug of high intrinsic clearance, in the isolated perfused rat liver preparation. J. Pharmacokinet. Biopharm. 12:129–147 (1984).

    Google Scholar 

  3. A. M. Evans, Z. Hussein, M. Rowland. A two-compartment dispersion model describes the hepatic outflow profile of diclofenac in the presence of its binding protein. J. Pharm. Pharmacol. 43:709–714 (1991).

    Google Scholar 

  4. J. M. Diaz-Garcia, A. M. Evans, M. Rowland. Application of the axial dispersion model of hepatic drug elimination to the kinetics of diazepam in the isolated perfused rat liver. J. Pharmacokinet. Biopharm. 20:171–193 (1992).

    Google Scholar 

  5. A. M. Evans, Z. Hussein, M. Rowland. Influence of albumin on the distribution and elimination of diclofenac in the isolated perfused rat liver: Analysis by impulse-response technique and the dispersion model. J. Pharm. Sci. 82:421–428 (1993).

    Google Scholar 

  6. M. Rowland, A. M. Evans. Physiologic models of hepatic elimination. New Trends in Pharmacokinetics. Eds A. Rescigno, A. K. Thakur. Plenum Press, New York, 1991.

    Google Scholar 

  7. M. S. Roberts, M. Rowland. A dispersion model of hepatic elimination. 1. Formulation of the model and bolus considerations. J. Pharmacokinet. Biopharm. 14:227–260 (1986).

    CAS  Google Scholar 

  8. Z. Hussein, A. M. Evans, M. Rowland. Physiologic models of hepatic clearance: Influence of altered protein binding on the elimination of diclofenac in the isolated perfused rat liver. J. Pharm. Sci. 82:880–885 (1993).

    Google Scholar 

  9. Y. Yano, K. Yamaoka, Y. Aoyama, H. Tanaka. Two-compartment dispersion model for analysis of organ perfusion system of drugs by fast inverse laplace transform (FILT). J. Pharmacokinet. Biopharm. 17:179–202 (1989).

    Google Scholar 

  10. E. Nelson, M. Hanano, G. Levy. Comparative pharmacokinetics of salicylate elimination in man and rats. J. Pharmacol. Exp. Ther. 153:159–166, 1966

    Google Scholar 

  11. T. Yoshikawa, Y. Sugiyama, Y. Sawada, T. Iga, M. Hanano. Effect of pregnancy on tissue distribution of salicylate in rats. Drug Metab. Dispos. 12:500–505 (1984).

    Google Scholar 

  12. J. Hirate, Y. Kato, I. Horikoshi, S. Nagase, C. T. Ueda. Further observations on the disposition characteristics of salicylic acid in analbuminemic rats. Biopharm. Drug Dispos. 10:299–309 (1989).

    Google Scholar 

  13. S. H. Dromgoole, D. E. Furst. Salicylates. In: Applied Pharmacokinetics Eds: W. E. Evans, J. J. Schentag, W. J. Jusko. Applied Therapeutic Inc., Spokane, WA, 1986.

    Google Scholar 

  14. M. Ichikawa, S. C. Tsao, T-H. Lin, S. Miyauchi, Y. Sawada, T. Iga, M. Hanano, Y. Sugiyama. Albumin-mediated transport phenomenon observed for ligands with high permeability: Effect of unstirred water layer in the disse's space of the rat liver. Hepatol. 16:38–49 (1992).

    Google Scholar 

  15. B. E. Cham, D. Johns, F. Bochner, D. M. Imhoff, M. Rowland. Simultaneous liquid-chromatographic separation of salicylic acid, salicyluric acid and gentisic acid in plasma. Clin. Chem. 25:1420–1425, (1979).

    Google Scholar 

  16. H. G. Boxenbaum, S. Riegelman, R. M. Elashoff. Statistical estimations in pharmacokinetics. J. Pharmacokinet. Biopharm. 2:123–148 (1974).

    Google Scholar 

  17. Y. Yano, K. Yamaoka, H. Yasui, T. Nakagawa. Effect of perfusion rate on the local disposition of cefixime in liver perfusion system based on two-compartment dispersion model. Drug Metab. Dispos. 19:1022–1027 (1991).

    Google Scholar 

  18. C. A. Goresky. Kinetic interpretation of hepatic multiple-indicator dilution studies. Am. J. Physiol. 245:G1–G12 (1983).

    Google Scholar 

  19. M. S. Roberts, S. Fraser, A. Wagner, L. McLeod. Residence time distribution of solutes in the perfused rat liver using a dispersion model of hepatic elimination: 1. Effect of changes in perfusate flow rate and albumin concentration on sucrose and taurocholate. J. Pharmacokinet. Biopharm. 18:209–234 (1990).

    Google Scholar 

  20. C. A. Goresky, M. Silverman. Effect of correction of catheter distortion on calculated liver sinusoidal volumes. Am J. Physiol. 207:883 (1964).

    Google Scholar 

  21. C-H. Chou, A. M. Evans, G. Fornasini, M. Rowland. Relationship between lipophilicity and hepatic dispersion and distribution for a homologous series of barbiturates in the isolated perfused in situ rat liver. Drug Metab. Dispos. 21:933–938 (1993).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hussein, Z., McLachlan, A.J. & Rowland, M. Distribution Kinetics of Salicylic Acid in the Isolated Perfused Rat Liver Assessed Using Moment Analysis and the Two-Compartment Axial Dispersion Model. Pharm Res 11, 1337–1345 (1994). https://doi.org/10.1023/A:1018958915171

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1018958915171

Navigation